Results 11 to 20 of about 103,755 (281)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. [PDF]
Clin Microbiol Rev, 2017 Wong D +5 more
europepmc +2 more sources
Risk Factors For Nosocomial Pan Drug Resistant Acinetobacter Baumannii Infections
Acta Medica Alanya, 2019 Aim: Acinetobacter baumannii is an important nosocomial pathogen. The purpose of this study was to identify risk factors and mortality of nosocomial infections caused by pan drug resistant (PDR) Acinetobacter baumannii and to characterize their effects ...
Havva Tünay +2 more
doaj +1 more source
Microbiology Spectrum, 2023 Infections by pathogenic Acinetobacter species represent a significant burden on the health care system, despite their relative rarity, due to the difficulty of treating infections through oral antibiotics.
Nam Vo +3 more
doaj +1 more source
Journal of Infection and Public Health, 2012 Summary: Background: Nosocomial Acinetobacter infections are an increasing concern in intensive care units (ICU). Objectives: To study the demographic and clinical characteristics and the outcomes of ICU patients with Acinetobacter infections.
Ashu Sara Mathai +3 more
doaj +1 more source
The transmission of nosocomial pathogens in an intensive care unit: a space–time clustering and structural equation modelling approach [PDF]
, 2010 We investigated the incidence of cases of nosocomial pathogens and risk factors in an intensive treatment unit ward to determine if the number of cases is dependent on location of patients and the colonization/infection history of the ward.
A. G. O'DONNELL +6 more
core +1 more source
Treatment ofAcinetobacterInfections [PDF]
Clinical Infectious Diseases, 2010 Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted ...
Joel, Fishbain, Anton Y, Peleg
openaire +4 more sources
Multi-drug resistant Gram-negative bacteria: antibiotic-resistance and new treatment strategies [PDF]
, 2017 In this editorial, we treat the multi-drug-resistance of microorganisms such as Klebsiella pneumonia (Kp) and Acinetobacter baumanii and the issues concerning the management of these infections.
Angelis, Massimiliano De +2 more
core +1 more source
Acinetobacter infections: A growing threat in the hospital
Journal of Marine Medical Society, 2013 Acinetobacter baumannii is a Gram Negative coccobacilli implicated in causation of wide spectrum of nosocomial infections. Multidrug resistant Acinetobacter (MDR Acinetobacter) is emerging as an important cause of hospital acquired infections like ...
Ruby Chattopadhyay +4 more
doaj +1 more source
Measures to eradicate multidrug-resistant organism outbreaks: How much does it cost? [PDF]
, 2015 This study aimed to assess the economic burden of infection control measures that succeeded in eradicating multidrug-resistant organisms (MDROs) in emerging epidemic contexts in hospital settings.
Birgand, GJC +6 more
core +1 more source
Bacteremia caused by an Acinetobacter junii strain harboring class 1 integron and diverse DNA mobile elements [PDF]
, 2014 INTRODUCTION: Infections caused by Acinetobacter junii are rarely reported. However, some outbreaks of septicemia in neonates and pediatric oncology patients, as well as meningitis, peritonitis, and ocular infection have been described.
Almuzara, Marisa +7 more
core +1 more source